172 Chapter 7 2012;26(9):891-907. doi:10.1101/gad.188326.112 57. Miller FD, et al. Timing is everything: making neurons versus glia in the developing cortex. Neuron. May 3 2007;54(3):357-69. doi:10.1016/j. neuron.2007.04.019 58. YangY,etal.Developmentalmaturationofastrocytes and pathogenesis of neurodevelopmental disorders. J Neurodev Disord. Aug 29 2013;5(1):22. doi:10.1186/1866-1955-5-22 59. Naruse M, et al. Origin of oligodendrocytes in mammalian forebrains: a revised perspective. J Physiol Sci. Jan 2017;67(1):63-70. doi:10.1007/ s12576-016-0479-7 60. Rowitch DH, et al. Developmental genetics of vertebrate glial-cell specification. Nature. Nov 11 2010;468(7321):214-22. doi:10.1038/nature09611 61. Durand B, et al. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays. Jan 2000;22(1):64-71. doi:10.1002/(SICI)15211878(200001)22:1<64::AID-BIES11>3.0.CO;2-Q 62. Ortega MC, et al. Megalin mediates the influence of sonic hedgehog on oligodendrocyte precursor cell migration and proliferation during development. Glia. May 2012;60(6):851-66. doi:10.1002/ glia.22316 63. Clemente D, et al. The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases. Front Cell Neurosci. Dec 20 2013;7:268. doi:10.3389/ fncel.2013.00268 64. See J, et al. Oligodendrocyte maturation is inhibited by bone morphogenetic protein. Mol Cell Neurosci. Aug 2004;26(4):481-92. doi:10.1016/j. mcn.2004.04.004 65. Lanciotti A, et al. Astrocytes: Emerging Stars in Leukodystrophy Pathogenesis. Transl Neurosci. Jun 1 2013;4(2)doi:10.2478/s13380-013-0118-1 66. Lundgaard I, et al. White matter astrocytes in health and disease. Neuroscience. Sep 12 2014;276:16173. doi:10.1016/j.neuroscience.2013.10.050 67. Camargo N, et al. Oligodendroglial myelination requires astrocyte-derived lipids. PLoS Biol. May 2017;15(5):e1002605. doi:10.1371/journal. pbio.1002605 68. Itoh N, et al. Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes. Proc Natl Acad Sci U S A. Jan 9 2018;115(2):E302-E309. doi:10.1073/ pnas.1716032115 69. Liu JP, et al. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci. Jan 2010;43(1):33-42. doi:10.1016/j. mcn.2009.07.013 70. Sweeney MD, et al. The role of brain vasculature in neurodegenerative disorders. Nat Neurosci. Oct 2018;21(10):1318-1331. doi:10.1038/s41593-0180234-x 71. Stephenson E, et al. Iron in multiple sclerosis: roles in neurodegeneration and repair. Nat Rev Neurol. Aug 2014;10(8):459-68. doi:10.1038/ nrneurol.2014.118 72. Morath DJ, et al. Iron deficiency during embryogenesis and consequences for oligodendrocyte generation in vivo. Dev Neurosci. 2002;24(2-3):197-207. doi:10.1159/000065688 73. Heneka MT, et al. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. Jul 2014;14(7):463-77. doi:10.1038/nri3705 74. Alvarez JI, et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science (New York, NY). 2011;334(6063):1727-1731. doi:10.1126/ science.1206936 75. Seo JH, et al. Oligodendrocyte precursor cells support blood-brain barrier integrity via TGFbeta signaling. PLOS ONE. 2014;9(7):e103174. doi:10.1371/journal.pone.0103174 76. Kimura I, et al. Oligodendrocytes upregulate blood-brain barrier function through mechanisms other than the PDGF-BB/PDGFRalpha pathway in the barrier-tightening effect of oligodendrocyte progenitor cells. Neurosci Lett. Jan 10 2020;715:134594. doi:10.1016/j. neulet.2019.134594 77. Niu J, et al. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nat Neurosci. May 2019;22(5):709-718. doi:10.1038/s41593-0190369-4 78. Giaume C, et al. Connexins, gap junctions, and glia. Wiley Interdisciplinary Reviews: Membrane Transport and Signaling. 2013/05/07 2013;2(4):133-142. doi:10.1002/wmts.87 79. Masaki K. Early disruption of glial communication via connexin gap junction in multiple sclerosis, Balo’s disease and neuromyelitis optica. Neuropathology. Oct 2015;35(5):469-80. doi:10.1111/neup.12211 80. Papaneophytou CP, et al. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination. Glia. Dec 2018;66(12):2589-2603. doi:10.1002/glia.23513 81. Boulay AC, et al. Immune quiescence of the brain is set by astroglial connexin 43. J Neurosci. Mar 11 2015;35(10):4427-39. doi:10.1523/ JNEUROSCI.2575-14.2015 82. Darbinyan A, et al. Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells. J Neurosci Res. Jan 2013;91(1):116-27. doi:10.1002/ jnr.23135 83. Ramesh G, et al. A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi. J Neuroinflammation. Apr 23 2012;9(1):72. doi:10.1186/1742-2094-9-72 84. Andjelkovic AV, et al. Functional expression of CCR2 by human fetal astrocytes. J Neurosci Res. Oct 15 2002;70(2):219-31. doi:10.1002/jnr.10372 85. Ashutosh, et al. CXCL8 protects human neurons
RkJQdWJsaXNoZXIy MTk4NDMw